| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Gefitinib in Central Nervous System Metastases in Patients with Non–Small-Cell Lung Cancer: Two Case Reports and a Review of the Literature
|
Gurpide, Alfonso
|
|
2005
|
7 |
Supplement 2 |
p. 138-140
3 p.
|
artikel
|
| 2 |
Activity of Novel Cytotoxic Agents in Lung Cancer: Epothilones and Topoisomerase I Inhibitors
|
Wakelee, Heather A.
|
|
2005
|
7 |
Supplement 2 |
p. S6-S12
7 p.
|
artikel
|
| 3 |
Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program
|
Thomas, Sheeba K.
|
|
2006
|
7 |
Supplement 2 |
p. 326-331
6 p.
|
artikel
|
| 4 |
Chemoprevention Strategies with Cyclooxygenase-2 Inhibitors for Lung Cancer
|
Mao, Jenny T.
|
|
2005
|
7 |
Supplement 2 |
p. 30-39
10 p.
|
artikel
|
| 5 |
Computed Tomography Screening for Lung Cancer: Applicability of an International Protocol in a Single-Institution Environment
|
Shaham, Dorith
|
|
2006
|
7 |
Supplement 2 |
p. 262-267
6 p.
|
artikel
|
| 6 |
Continuous-Infusion Vinorelbine for the Treatment of Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study
|
Carabante-Ocôn, Francisco
|
|
2005
|
7 |
Supplement 2 |
p. 121-126
6 p.
|
artikel
|
| 7 |
Efficacy and Safety of Paclitaxel Poliglumex as First-Line Chemotherapy in Patients at High Risk with Advanced-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Study
|
Richards, Donald A.
|
|
2005
|
7 |
Supplement 2 |
p. 215-220
6 p.
|
artikel
|
| 8 |
First-Line Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer: Focus on Docetaxel
|
Ramalingam, Suresh
|
|
2005
|
7 |
Supplement 2 |
p. S77-S82
6 p.
|
artikel
|
| 9 |
Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non-Small-Cell Lung Cancer
|
Reck, Martin
|
|
2006
|
7 |
Supplement 2 |
p. 406-411
6 p.
|
artikel
|
| 10 |
Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules
|
Obasaju, Coleman K.
|
|
2005
|
7 |
Supplement 2 |
p. 202-207
6 p.
|
artikel
|
| 11 |
Induction Paclitaxel/Carboplatin Followed by Concurrent Chemoradiation Therapy for Unresectable Stage III Non–Small-Cell Lung Cancer: A Limited-Access Study (CALGB 9534)
|
Akerley, Wallace
|
|
2005
|
7 |
Supplement 2 |
p. 47-53
7 p.
|
artikel
|
| 12 |
Influence of Sex on Lung Cancer Histology, Stage, and Survival in a Midwestern United States Tumor Registry
|
Ringer, Geoffrey
|
|
2005
|
7 |
Supplement 2 |
p. 180-182
3 p.
|
artikel
|
| 13 |
Multicenter Phase II Trial of Carboplatin/Vinorelbine in Elderly Patients with Advanced Non–Small-Cell Lung Cancer–Efficacy and Impact on Quality of Life: Groupe Français de Pneumo-Cancérologie Study 9902
|
LeCaer, Hervé
|
|
2005
|
7 |
Supplement 2 |
p. 114-120
7 p.
|
artikel
|
| 14 |
Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin
|
Schuette, Wolfgang
|
|
2006
|
7 |
Supplement 2 |
p. 338-343
6 p.
|
artikel
|
| 15 |
Multivariate Analysis of Survival, Local Control, and Time to Distant Metastases in Patients with Unresectable Non–Small-Cell Lung Carcinoma Treated with 3-Dimensional Conformal Radiation Therapy with or Without Concurrent Chemotherapy
|
Wolski, Michal J.
|
|
2005
|
7 |
Supplement 2 |
p. 100-106
7 p.
|
artikel
|
| 16 |
Neglected and Underrepresented Subpopulations: Elderly and Performance Status 2 Patients with Advanced-Stage Non-Small-Cell Lung Cancer
|
Langer, Corey J.
|
|
2006
|
7 |
Supplement 2 |
p. S126-S137
12 p.
|
artikel
|
| 17 |
Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program
|
Jänne, Pasi A.
|
|
2005
|
7 |
Supplement 2 |
p. 40-46
7 p.
|
artikel
|
| 18 |
Paclitaxel Poliglumex/Carboplatin Is Similar to Paclitaxel/Carboplatin as First-Line Treatment in Elderly Patients with Advanced Non–Small-Cell Lung Cancer and a Poor Performance Status
|
Reddy, G. Kesava
|
|
2005
|
7 |
Supplement 2 |
p. 20-22
3 p.
|
artikel
|
| 19 |
Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer
|
Schuette, Wolfgang
|
|
2005
|
7 |
Supplement 2 |
p. 133-137
5 p.
|
artikel
|
| 20 |
PIONEER: A Phase III Randomized Trial of Paclitaxel Poliglumex Versus Paclitaxel in Chemotherapy-Naive Women with Advanced-Stage Non-Small-Cell Lung Cancer and Performance Status of 2
|
Albain, Kathy S.
|
|
2006
|
7 |
Supplement 2 |
p. 417-419
3 p.
|
artikel
|
| 21 |
Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid
|
Krug, Lee M.
|
|
2006
|
7 |
Supplement 2 |
p. 257-261
5 p.
|
artikel
|
| 22 |
Primary Malignant Melanoma of the Lung: A Case Report and Review of the Literature
|
Kundranda, Madappa N.
|
|
2006
|
7 |
Supplement 2 |
p. 279-281
3 p.
|
artikel
|
| 23 |
Proteasome Inhibition in Small-Cell Lung Cancer: Preclinical Rationale and Clinical Applications
|
Lara Jr, Primo N.
|
|
2005
|
7 |
Supplement 2 |
p. S67-S71
5 p.
|
artikel
|
| 24 |
Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer
|
Manegold, Christian
|
|
2005
|
7 |
Supplement 2 |
p. 208-214
7 p.
|
artikel
|
| 25 |
Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer
|
Tibaldi, Carmelo
|
|
2006
|
7 |
Supplement 2 |
p. 401-405
5 p.
|
artikel
|
| 26 |
Sequential Versus Alternating Administration of Cisplatin/Etoposide and Topotecan as First-Line Treatment in Extensive-Stage Small-Cell Lung Cancer: Preliminary Results of a Phase III Trial of the Hellenic Oncology Research Group
|
Ignatiadis, Michail
|
|
2005
|
7 |
Supplement 2 |
p. 183-189
7 p.
|
artikel
|
Tijdschrift beschrijving